Ridgeline Discovery

Ridgeline, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry, and leading academics across Europe, US and RoW. In recent years, Ridgeline has assembled an international team of highly experienced drug discovery and industry professionals and built and operated multiple new successful companies; these companies have raised significant funds through Series B, IPO, Pharma Partnerships and an exit through a trade sale.